Carolinas Wealth Consulting’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,562	Closed	-$456K	–	424
2025 Q1	$456K	Buy	3,562 +151	+4%	+$20.5K	0.1%	111
2024 Q4	$451K	Sell	3,411 -48	-1%	-$6.75K	0.09%	114
2024 Q3	$503K	Buy	3,459 +2	+0.1%	+$289	0.09%	109
2024 Q2	$474K	Buy	3,457 +1	+0%	+$133	0.09%	109
2024 Q1	$474K	Sell	3,456 -19	-0.5%	-$2.6K	0.09%	104
2023 Q4	$472K	Hold	3,475	–	–	0.1%	93
2023 Q3	$395K	Sell	3,475 -334	-9%	-$42.5K	0.1%	96
2023 Q2	$484K	Sell	3,809 -517	-12%	-$67.2K	0.1%	104
2023 Q1	$559K	Buy	4,326 +70	+2%	+$9.16K	0.12%	93
2022 Q4	$559K	Buy	4,256 +951	+29%	+$123K	0.13%	88
2022 Q3	$387K	Buy	3,305 +3	+0.1%	+$373	0.1%	106
2022 Q2	$388K	Buy	3,302 +1	+0%	+$119	0.1%	101
2022 Q1	$430K	Buy	3,301 +2	+0.1%	+$261	0.1%	99
2021 Q4	$504K	Hold	3,299	–	–	0.11%	90
2021 Q3	$533K	Sell	3,299 -1,239	-27%	-$209K	0.12%	82
2021 Q2	$743K	Buy	4,538 +1	+0%	+$154	0.16%	64
2021 Q1	$683K	Buy	4,537 +3	+0.1%	+$477	0.17%	67
2020 Q4	$687K	Sell	4,534 -11,205	-71%	-$1.6M	0.18%	64
2020 Q3	$2.13M	Sell	15,739 -193	-1%	-$26.2K	0.72%	29
2020 Q2	$2.18M	Buy	+15,932	New	+$2.03M	0.86%	25